1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporos. Am J Med 1993;94:646–650. PMID:
8506892.
2. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465–475. PMID:
17144789.
3. Park C, Ha YC, Jang S, Yoon HK, Lee YK. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab 2011;29:744–751. PMID:
21644058.
4. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B,
et al. Assessment of fracture risk. Osteoporos Int 2005;16:581–589. PMID:
15616758.
5. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P,
et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005;20:1185–1194. PMID:
15940371.
6. Arden NK, Baker J, Hogg C, Baan K, Spector TD. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 1996;11:530–534. PMID:
8992884.
7. Hardy J, Singleton A. Genomewide association studies and human disease. New Engl J Med 2009;360:1759–1768. PMID:
19369657.
8. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010;363:166–176. PMID:
20647212.
9. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG,
et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008;371:1505–1512. PMID:
18455228.
10. Rivadeneira F, Styrkársdottir U, Estrada K, Halldórsson BV, Hsu YH, Richards JB,
et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 2009;41:1199–1206. PMID:
19801982.
11. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T,
et al. New sequence variants associated with bone mineral density. Nat Genet 2009;41:15–17. PMID:
19079262.
12. Richards JB, Kavvoura FK, Rivadeneira F, Styrkársdóttir U, Estrada K, Halldórsson BV,
et al. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med 2009;151:528–537. PMID:
19841454.
13. Duncan EL, Danoy P, Kemp JP, Leo PJ, McCloskey E, Nicholson GC,
et al. Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet 2011;7:e1001372. PMID:
21533022.
14. Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL,
et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med 2006;145:255–264. PMID:
16908916.
15. Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB,
et al. Differential genetic effects of
ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 2004;292:2105–2114. PMID:
15523071.
16. Kung AW, Xiao SM, Cherny S, Li GH, Gao Y, Tso G,
et al. Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am J Hum Genet 2010;86:229–239. PMID:
20096396.
17. Peacock M, Turner CH, Econs MJ, Foroud T. Genetics of osteoporosis. Endocr Rev 2002;23:303–326. PMID:
12050122.
18. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE,
et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012;44:491–501. PMID:
22504420.
19. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ,
et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009;41:527–534. PMID:
19396169.
20. Rabbee N, Speed TP. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 2006;22:7–12. PMID:
16267090.
21. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5:e1000529. PMID:
19543373.
22. O'Connell J, Gurdasani D, Delaneau O, Pirastu N, Ulivi S, Cocca M,
et al. A general approach for haplotype phasing across the full spectrum of relatedness. PLoS Genet 2014;10:e1004234. PMID:
24743097.
23. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M,
et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 2013;41:D64–D69. PMID:
23155063.
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D,
et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559–575. PMID:
17701901.
25. Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of genomes. Nat Methods 2011;9:179–181. PMID:
22138821.
26. Dayem Ullah AZ, Lemoine NR, Chelala C. SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update). Nucleic Acids Res 2012;40:W65–W70. PMID:
22544707.
27. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073–1081. PMID:
19561590.
28. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002;30:3894–3900. PMID:
12202775.
29. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A,
et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006;34:D108–D110. PMID:
16381825.
30. Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 2013;19:179–192. PMID:
23389618.
31. Kikuchi A, Yamamoto H, Sato A. Selective activation mechanisms of Wnt signaling pathways. Trends Cell Biol 2009;19:119–129. PMID:
19208479.
32. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 2011;13:27–38. PMID:
22189423.
33. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998;(335 Suppl):S247–S256. PMID:
9917644.
34. Krampera M, Pizzolo G, Aprili G, Franchini M. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 2006;39:678–683. PMID:
16765663.
35. Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, Passuti N,
et al. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 2003;163:2021–2031. PMID:
14578201.
36. Yogo K, Ishida-Kitagawa N, Takeya T. Negative autoregulation of RANKL and c-Src signaling in osteoclasts. J Bone Miner Metab 2007;25:205–210. PMID:
17593489.
37. Hamdy NA. Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis. Curr Opin Investig Drugs 2007;8:299–303.
38. Khan KM, Sarafoglou K, Somani A, Frohnert B, Miller BS. Can ultrasound be used to estimate bone mineral density in children with growth problems? Acta Paediatr 2013;102:e407–e412. PMID:
23750846.